We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
(-12%)
Cap. Flow
-$392M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$100M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$97M |
| 3 |
Lam Research
LRCX
|
+$85.4M |
| 4 |
Boston Scientific
BSX
|
+$79.4M |
| 5 |
Merck
MRK
|
+$67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$145M |
| 2 |
ASML
ASML
|
+$119M |
| 3 |
Qorvo
QRVO
|
+$89M |
| 4 |
Microsoft
MSFT
|
+$82.9M |
| 5 |
Intuitive Surgical
ISRG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.56% |
| 2 | Technology | 29.01% |
| 3 | Industrials | 8.79% |
| 4 | Communication Services | 5.99% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Paycom
PAYC
$8.16B
| $9.96M | 0.16% |
28,760
-17,571
| -38% | -$5.89M |
|
177
Relay Therapeutics
RLAY
$4.24B
| $9.93M | 0.16% |
331,663
+76,062
| +30% | +$1.85M |
|
|
DMYS
178
DELISTED
dMY Technology Group, Inc. VI
DMYS
| $9.87M | 0.16% |
1,000,000
| – | – |
|
179
Booz Allen Hamilton
BAH
$8.72B
| $9.86M | 0.16% |
+112,273
| New | +$9.24M |
|
180
Xerox
XRX
$413M
| $9.66M | 0.16% |
+478,891
| New | +$10.1M |
|
181
Ulta Beauty
ULTA
$23.3B
| $9.57M | 0.16% |
24,044
+41
| +0.2% | +$15.4K |
|
|
TEN
182
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $9.2M | 0.15% |
+502,200
| New | +$7.2M |
|
183
CDW
CDW
$17.5B
| $9.02M | 0.15% |
+50,403
| New | +$9.22M |
|
|
SAVE
184
DELISTED
Spirit Airlines, Inc.
SAVE
| $8.88M | 0.14% |
+405,854
| New | +$9.29M |
|
185
Clear Channel Outdoor Holdings
CCO
$1.23B
| $8.72M | 0.14% |
2,519,556
-507,452
| -17% | -$1.72M |
|
186
Visa
V
$687B
| $8.56M | 0.14% |
38,607
-4,193
| -10% | -$907K |
|
187
Walmart Inc
WMT
$896B
| $8.33M | 0.14% |
+167,826
| New | +$7.88M |
|
|
MTOR
188
DELISTED
MERITOR, Inc.
MTOR
| $8.27M | 0.13% |
+232,450
| New | +$6.87M |
|
189
Denali Therapeutics
DNLI
$3.83B
| $8.26M | 0.13% |
256,678
+204,224
| +389% | +$7.03M |
|
190
Arcus Biosciences
RCUS
$3.59B
| $8.25M | 0.13% |
261,419
-1,445,006
| -85% | -$48.4M |
|
|
FOLD
191
DELISTED
Amicus Therapeutics
FOLD
| $8.19M | 0.13% |
+864,282
| New | +$8.1M |
|
|
SNRH
192
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
| $8.04M | 0.13% |
818,975
| – | – |
|
193
Tenet Healthcare
THC
$20.9B
| $7.99M | 0.13% |
92,970
+25,975
| +39% | +$2.13M |
|
|
EXAI
194
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $7.92M | 0.13% |
550,027
-1,684
| -0.3% | -$28.7K |
|
|
CNTA
195
DELISTED
Centessa Pharmaceuticals
CNTA
| $7.92M | 0.13% |
882,633
+81,497
| +10% | +$743K |
|
|
RAPT
196
DELISTED
RAPT Therapeutics
RAPT
| $7.88M | 0.13% |
+44,805
| New | +$8.46M |
|
197
Dyne Therapeutics
DYN
$4.95B
| $7.84M | 0.13% |
813,139
+298,538
| +58% | +$2.54M |
|
|
OKLO
198
Oklo
OKLO
$7.46B
| $7.81M | 0.13% |
800,000
| – | – |
|
199
PTC Therapeutics
PTCT
$5.81B
| $7.78M | 0.13% |
208,493
-327,451
| -61% | -$12.6M |
|
200
Okta
OKTA
$25.8B
| $7.54M | 0.12% |
+49,914
| New | +$8.95M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.
- Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
- Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
- Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
- Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
- Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
- Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
- Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.
Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.